His main research concerns Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Liver transplantation. His studies in Internal medicine integrate themes in fields like Ribavirin, Hepatitis C virus, Immunology and Pathology. His Gastroenterology study integrates concerns from other disciplines, such as Hepatocellular carcinoma and Liver biopsy.
Richard K. Sterling interconnects Microbiome, Metabolome, Hepatology and Cohort in the investigation of issues within Cirrhosis. The Hepatitis C study combines topics in areas such as Hepatitis B and Liver function tests. Richard K. Sterling has researched Liver transplantation in several fields, including Anesthesia and Intensive care.
Richard K. Sterling focuses on Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Immunology. His studies examine the connections between Internal medicine and genetics, as well as such issues in Hepatitis C virus, with regards to Coinfection. Richard K. Sterling works mostly in the field of Gastroenterology, limiting it down to concerns involving Liver biopsy and, occasionally, Steatosis.
His study looks at the relationship between Cirrhosis and fields such as Prospective cohort study, as well as how they intersect with chemical problems. He has included themes like Clinical trial, Cohort study, Liver function tests, Viral load and Hepatology in his Hepatitis C study. The study incorporates disciplines such as Rifaximin and Pediatrics in addition to Hepatic encephalopathy.
His primary scientific interests are in Internal medicine, Gastroenterology, Cirrhosis, Liver disease and Hepatitis C. The concepts of his Gastroenterology study are interwoven with issues in Nonalcoholic fatty liver disease, Liver biopsy and Hepatitis B virus. His work is dedicated to discovering how Liver biopsy, Coinfection are connected with HBsAg and HBeAg and other disciplines.
His Cirrhosis research includes elements of Liver cancer, Rifaximin and Hepatitis C virus. His research integrates issues of Odds ratio and Fatty liver in his study of Liver disease. His Hepatitis C research is multidisciplinary, relying on both Clinical trial, Sofosbuvir, Confidence interval, Grazoprevir and Elbasvir.
His primary areas of study are Internal medicine, Gastroenterology, Hepatitis B virus, Hepatitis B and Liver disease. His study in Cirrhosis, Cohort study, Hepatitis C, Confidence interval and Clinical trial falls under the purview of Internal medicine. His Cirrhosis research integrates issues from Encephalopathy and Hepatology.
His biological study spans a wide range of topics, including Liver biopsy and Hepatitis C virus. His research investigates the connection with Hepatitis B virus and areas like Hepatocellular carcinoma which intersect with concerns in Oncology. His Liver disease research incorporates themes from Coinfection and Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling;Eduardo Lissen;Eduardo Lissen;Nathan Clumeck;Ricard Sola.
Nonalcoholic Steatohepatitis: Association of Insulin Resistance and Mitochondrial Abnormalities
Arun J. Sanyal;Carol Campbell-Sargent;Faridoddin Mirshahi;William B. Rizzo.
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
Pouneh Mofrad;Melissa J. Contos;Mahmadul Haque;Carol Sargeant.
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie.
Right lobe living donor liver transplantation.
Amadeo Marcos;Robert A. Fisher;John M. Ham;Mitchell L. Shiffman.
SIMILARITIES AND DIFFERENCES IN OUTCOMES OF CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS AND HEPATITIS C
Arun J. Sanyal;Colin Banas;Carol Sargeant;Velimir A. Luketic.
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
Anna S. Lok;Richard K. Sterling;James E. Everhart;Elizabeth C. Wright.
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
Arun J. Sanyal;Pouneh S. Mofrad;Melissa J. Contos;Carol Sargeant.
Clinical Gastroenterology and Hepatology (2004)
The plasma lipidomic signature of nonalcoholic steatohepatitis.
Puneet Puri;Michelle M. Wiest;Onpan Cheung;Faridoddin Mirshahi.
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Melissa J. Contos;Wendy Cales;Richard K. Sterling;Velimir A. Luketic.
Liver Transplantation (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: